Complete Surgical Excision Is the Most Effective Treatment for BI-ALCL
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.